CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The investigators aim to investigate the incidence of migraine attacks after calcitonin gene-related peptide (CGRP) infusion in patients who have tried anti-CGRP monoclonal antibody treatment for the prevention of migraine.
Epistemonikos ID: bf517e557cb839ddf1e2611beb0a1d95a262935c
First added on: May 21, 2024